Pfizer announces positive top-line results from phase III Lot Consistency Study of 20-Valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest